探讨介入治疗对晚期胰腺癌的疗效  

The efficacy discussion of interventional therapy for advanced pancreatic carcinoma

作　　者：宋恬[1] 殷士蒙[1] 孙荣跃[1] 沈岚[1] 钱愉[1] 

机构地区：[1]上海华东医院放射科,200040

出　　处：《介入放射学杂志》2008年第6期411-413,共3页Journal of Interventional Radiology

摘　　要：目的评价介入治疗对晚期胰腺癌的疗效。方法收集2005年4月起在本科做介入治疗的33例晚期胰腺癌患者的资料。所有患者均为不能手术的晚期胰腺癌患者,均接受1次或多次介入治疗。重复治疗者间隔时间为6周,所有患者均接受腹腔动脉和肠系膜上动脉化疗灌注,给药比例为2∶1,术后未发现严重并发症。结果患者术后自觉疼痛、腹胀等不适症状明显减轻甚至消失,有效缓解率为91%(30/33)。所有患者术后CT复查显示癌肿均有不同程度缩小,缩小≥90%者占78.8%(26/33)。介入治疗后生存期平均为13个月,目前仍有26例存活,最长者已存活21个月。结论介入治疗可作为晚期胰腺癌不能手术者的首选疗法。Objective To evaluate the efficacy of interventional therapy for advanced pancreatic carcinoma. Methods 33 cases of advanced pancreatic carcinoma accepted interventional therapy from April 2005 were retrospectively analyzed. All patients were unoperable and accepted one or more times of celiac and superior mesenteric arterial chemotheraputics perfusion with dosage of 2：1. The embolization was further introduced with the addition of liver invasion. The repetition interval was kept at 6 weeks with no severe complications. Results The one with follow-up CT imagings showed obvious decrease of the lesion size, together with release or disappearance of the sensation of abdominal pain and abdominal distention. The life span prolonged with average survival of 13 months, including the longest of 22 months and the life quality improved. Conclusions The interventional therapy could be the first method of choice in the management of advanced pancreatic carcinoma.

关 键 词：胰腺癌 介入治疗 化疗灌注 

分 类 号：R735.9[医药卫生—肿瘤]